“The introduction of this new painkiller into the market poses a significant risk to individuals already addicted to opiates and to the public at large,” Governor Patrick said in a news release.
Whether from lack of oversight or lack of concern regarding America’s deadly opioid dependence, Zohydro formulators, Zogenix, designed the drug without tamper resistant properties. Users of the drug can easily crush the medication in order to snort or inject the medication for a quick high. Oxycodone lacked taper resistant features when it was first released and over the course of a few years the prescription drug epidemic inflated beyond belief.
Despite the drugs deadly auspices, the Food and Drug Administration (FDA) approved the drug even though a panel of experts assembled by the FDA itself voted against recommending approval. The FDA’s panel voted 11-2 against approval, saying that while the drug maker Zogenix met certain standards, the analgesic could be used by opioid addicts currently abusing oxycodone.
Public health groups and legislators are up in arms about the FDA’s approval, bombarding FDA Commissioner Margaret Hamburg with letters regarding the decision. Hamburg has also been contacted by 28 state attorneys general and four senators, pleading the FDA to reconsider its approval of Zohydro.
In a statement, Zogenix said, “We believe Governor Patrick’s ban on Zohydro ER only serves to unfairly restrict patient access to the only hydrocodone pain reliever available for long-term, daily, severe chronic pain patients who are obtaining relief with short-acting hydrocodone combination products, but who are at risk for potentially fatal liver toxicity due to their daily intake of acetaminophen. Ultimately, the ban on the prescription medication will add to patient suffering in the state.”
Zogenix has announced it will create an oversight board designed to spot misuse of Zohydro.